Literature DB >> 29121725

Real-world study of low-density lipoprotein cholesterol levels and cardiovascular outcomes in Chinese: A retrospective cohort study in post-percutaneous coronary intervention acute coronary syndrome patients.

Yun Wang1, Bryan P Yan2, Michael B Nichol3, Brian Tomlinson4, Vivian W Y Lee5.   

Abstract

BACKGROUND: This study aimed to assess the effect of low-density lipoprotein cholesterol (LDL-C) goal attainments (of <2.6mmol/L and <1.8mmol/L) on first major adverse cardiovascular events (MACEs) for acute coronary syndrome (ACS) patients who underwent percutaneous coronary intervention (PCI).
METHODS: A retrospective cohort study was conducted using case reviews of post-PCI ACS patients at an acute public hospital in Hong Kong between January 2009 and August 2015. Patients were followed from the date of PCI procedure until the first documented MACE (including all-cause death, myocardial infarction, heart failure, documented unstable angina, revascularization, and stroke) or to the end of the first year. Kaplan-Meier estimates were used to evaluate the impact of LDL-C goal attainments prior to the event on event-free time.
RESULTS: A total of 1684 patients were identified (79.0% males). At one-year endpoint, 658 (39.1%) attained the LDL-C goal of <1.8mmol/L, 727 (43.2%) had the LDL-C level between 1.8mmol/L and 2.6mmol/L, and 299 (17.8%) had the LDL-C level≥2.6mmol/L. About 10% experienced a MACE within one year. After adjustment for other available risk factors, attainment of LDL-C goal <2.6mmol/L was significantly associated with lower rates of MACEs during the one-year follow-up; and those who achieved the LDL-C level of 1.8mmol/L did not seem to carry any incremental clinical benefits.
CONCLUSIONS: Among post-PCI ACS patients, we merely observed a high correlation between the lipid goal attainment of <2.6mmol/L and MACEs through one-year follow-up, but not for the goal of <1.8mmol/L.
Copyright © 2017 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Acute coronary syndrome (ACS); Chinese; Lipid goal; Low-density lipoprotein cholesterol (LDL-C); Major adverse cardiovascular events (MACE)

Mesh:

Substances:

Year:  2017        PMID: 29121725     DOI: 10.1016/j.ijcard.2017.07.016

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  4 in total

1.  Analysis of risk factors for different subtypes of acute coronary syndrome.

Authors:  Lei Zhang; Juledezi Hailati; Xiaoyun Ma; Jiangping Liu; Zhiqiang Liu; Yuchun Yang; Pengyi He; Muhuyati Wulasihan
Journal:  J Int Med Res       Date:  2021-05       Impact factor: 1.671

2.  Descriptive analysis of real-world medication use pattern of statins and antiplatelet agents among patients with acute coronary syndrome in Hong Kong and the USA.

Authors:  Yun Wang; Michael B Nichol; Bryan Py Yan; Joanne Wu; Brian Tomlinson; Vivian Wy Lee
Journal:  BMJ Open       Date:  2019-07-16       Impact factor: 2.692

3.  Clinical and Economic Analysis of Lipid Goal Attainments in Chinese Patients with Acute Coronary Syndrome Who Received Post-Percutaneous Coronary Intervention.

Authors:  Yun Wang; Bryan Ping Yen Yan; Brian Tomlinson; Michael Bruce Nichol; Vivian Wing Yan Lee
Journal:  J Atheroscler Thromb       Date:  2018-06-29       Impact factor: 4.928

Review 4.  Role of Lipid-Lowering Therapy in Low-Density Lipoprotein Cholesterol Goal Attainment: Focus on Patients With Acute Coronary Syndrome.

Authors:  Qinqin Wang; Chun Liang
Journal:  J Cardiovasc Pharmacol       Date:  2020-12       Impact factor: 3.271

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.